Aptorum Group Limited Class A Aktie News

Das nach der Fusion entstehende Unternehmen, Niki BioSolutions, Inc., wird unter dem Ticker „NIKI“ an der Nasdaq gehandelt werden

NEW YORK, NY; NEW HAVEN, CT; und PRINCETON, NJ, 08. Juli 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group") , ein klinisch im Stadium befindliches biopharmazeutisches Unternehmen, das sich der Behandlung bisher ungedeckter medizinischer Bedürfnisse widmet, und DiamiR Biosciences ("DiamiR"), ein Entwickler innovativer blutbasierter Diagnosetests für Gehirngesundheit u...

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs. and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced a collabor...

NEW YORK, NY, June 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company dedicated to addressing unmet medical needs, today announced that at its shareholder meeting held on June 9, 2026, its shareholders voted to approve the proposed merger transaction with DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative bloo...